news on tirzepatide FDA confirms shortage is still over, gives compounders a grace period Month 4 Weigh-In Update on

Weight Rebound After GLP-1 GLP-1 medications are intended to be taken indefinitely, but prohibitive costs, shortages, or side effects have caused some users to stretch out or halt treatments entirely

Several clinical trials have explored the potential of GLP-1 receptor agonists in Parkinson's disease, with exenatide being the most extensively studied agent to date

Neuroprotective and Cognitive Support Effects : BPC-157s ability to promote neuronal repair is complemented by KPVs mitochondrial protective effects in neural tissue

doi: 10.1016/j.nut.2013.12.009 22 WangYWuYWangYFuAGongLLiWet al

This can lead to numerous improvements in health, including: Weight loss Improved glycemic control (a.k.a